Communicable Diseases Intelligence最新文献

{"title":"Invasive pneumococcal disease in Australia, 2011 and 2012.","authors":"Cindy Toms,&nbsp;Rachel de Kluyver","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In Australia, there were 1,883 cases (8.3 per 100,000 population) of invasive pneumococcal disease (IPD) notified to the National Notifiable Diseases Surveillance System (NNDSS) in 2011 and 1,823 cases (8.0 per 100,000) in 2012. The overall rate of IPD in Indigenous Australians was 9 times the rate of IPD in non-Indigenous Australians in 2011 and 7 times in 2012. Following the July 2011 introduction of the 13-valent pneumococcal conjugate vaccine (13vPCV) to the National Immunisation Program, rates of IPD in children aged less than 5 years decreased from 19.5 per 100,000 in 2011 to 12.6 per 100,000 in 2012. In Indigenous adults aged 50 years or over the rates of IPD caused by serotypes included in the 23-valent pneumococcal polysaccharide vaccine (23vPPV) continued to increase in both 2011 (47.2 per 100,000) and 2012 (51.2 per 100,000). The rates of IPD in non-Indigenous adults aged 65 years or over caused by serotypes included in the 23vPPV also increased in 2011 (10.1 per 100,000) and 2012 (11.2 per 100,000). There were 134 deaths attributable to IPD in 2011 and 126 in 2012, although it should be noted that deaths may be under-reported. The number of invasive pneumococcal isolates with reduced penicillin susceptibility remained low and reduced susceptibility to ceftriaxone/cefotaxime continued to be rare. </p>","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 2","pages":"E267-84"},"PeriodicalIF":2.5,"publicationDate":"2016-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34306475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Estimates of influenza vaccine coverage from Victorian surveillance systems based in the community, primary care and hospitals.","authors":"Benjamin Coghlan,&nbsp;Heath A Kelly,&nbsp;Sandra J Carlson,&nbsp;Kristina A Grant,&nbsp;Karin Leder,&nbsp;Craig B Dalton,&nbsp;Allen C Cheng","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 2","pages":"E204-6"},"PeriodicalIF":2.5,"publicationDate":"2016-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34753410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Australian Group on Antimicrobial Resistance Australian Enterobacteriaceae Sepsis Outcome Programme annual report, 2014.","authors":"Jan M Bell,&nbsp;John D Turnidge,&nbsp;Geoffrey W Coombs,&nbsp;Denise A Daley,&nbsp;Thomas Gottlieb,&nbsp;Jenny Robson,&nbsp;Narelle George","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The Australian Group on Antimicrobial Resistance performs regular period-prevalence studies to monitor changes in antimicrobial resistance in selected enteric Gram-negative pathogens. The 2014 survey was the second year to focus on blood stream infections. During 2014, 5,798 Enterobacteriaceae species isolates were tested using commercial automated methods (Vitek 2, BioMérieux; Phoenix, BD) and results were analysed using the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints (January 2015). Of the key resistances, non-susceptibility to the third-generation cephalosporin, ceftriaxone, was found in 9.0%/9.0% of Escherichia coli (CLSI/EUCAST criteria) and 7.8%/7.8% of Klebsiella pneumoniae, and 8.0%/8.0% K. oxytoca. Non-susceptibility rates to ciprofloxacin were 10.4%/11.6% for E. coli, 5.0%/7.7% for K. pneumoniae, 0.4%/0.4% for K. oxytoca, and 3.5%/6.5% in Enterobacter cloacae. Resistance rates to piperacillin-tazobactam were 3.2%/6.8%, 4.8%/7.2%, 11.1%/11.5%, and 19.0%/24.7% for the same 4 species respectively. Fourteen isolates were shown to harbour a carbapenemase gene, 7 blaIMP-4, 3 blaKPC-2, 3 blaVIM-1, 1 blaNDM-4, and 1 blaOXA-181-lke. </p>","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 2","pages":"E229-35"},"PeriodicalIF":2.5,"publicationDate":"2016-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34306471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Australian Group on Antimicrobial Resistance Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2014.","authors":"Geoffrey W Coombs,&nbsp;Denise A Daley,&nbsp;Yung Thin Lee,&nbsp;Julie C Pearson,&nbsp;J Owen Robinson,&nbsp;Graeme R Nimmo,&nbsp;Peter Collignon,&nbsp;Benjamin P Howden,&nbsp;Jan M Bell,&nbsp;John D Turnidge","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>From 1 January to 31 December 2014, 27 institutions around Australia participated in the Australian Staphylococcal Sepsis Outcome Programme (ASSOP). The aim of ASSOP 2014 was to determine the proportion of Staphylococcus aureus bacteraemia (SAB) isolates in Australia that are antimicrobial resistant, with particular emphasis on susceptibility to methicillin and to characterise the molecular epidemiology of the isolates. Overall, 18.8% of the 2,206 SAB episodes were methicillin resistant, which was significantly higher than that reported in most European countries. The 30-day all-cause mortality associated with methicillin-resistant SAB was 23.4%, which was significantly higher than the 14.4% mortality associated with methicillin-sensitive SAB (P <0.0001). With the exception of the beta-lactams and erythromycin, antimicrobial resistance in methicillin-sensitive S. aureus remains rare. However in addition to the beta-lactams, approximately 50‰ of methicillin-resistant S. aureus (MRSA) were resistant to erythromycin and ciprofloxacin and approximately 15% were resistant to co-trimoxazole, tetracycline and gentamicin. When applying the European Committee on Antimicrobial Susceptibility Testing breakpoints, teicoplanin resistance was detected in 2 S. aureus isolates. Resistance was not detected for vancomycin or linezolid. Resistance to non-beta-lactam antimicrobials was largely attributable to 2 healthcare-associated MRSA clones; ST22-IV [2B] (EMRSA-15) and ST239-III [3A] (Aus-2/3 EMRSA). ST22-IV [2B] (EMRSA-15) has become the predominant healthcare associated clone in Australia. Sixty per cent of methicillin-resistant SAB were due to community-associated (CA) clones. Although polyclonal, almost 44% of community-associated clones were characterised as ST93-IV [2B] (Queensland CA-MRSA) and ST1-IV [2B] (WA1). CA-MRSA, in particular the ST45-V [5C2&5] (WA84) clone, has acquired multiple antimicrobial resistance determinants including ciprofloxacin, erythromycin, clindamycin, gentamicin and tetracycline. As CA-MRSA is well established in the Australian community it is important that antimicrobial resistance patterns in community and healthcare-associated SAB is monitored as this information will guide therapeutic practices in treating S. aureus sepsis. </p>","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 2","pages":"E244-54"},"PeriodicalIF":2.5,"publicationDate":"2016-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34306473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"OzFoodNet quarterly report, 1 April to 30 June 2014.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 2","pages":"E290-6"},"PeriodicalIF":2.5,"publicationDate":"2016-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34306476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"National Notifiable Diseases Surveillance System, 1 January to 31 March 2016.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 2","pages":"E297-303"},"PeriodicalIF":2.5,"publicationDate":"2016-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34306477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Australian childhood immunisation coverage, 1 October to 30 September cohort, assessed as at 31 December 2015.","authors":"Alexandra Hendry","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 2","pages":"E304-5"},"PeriodicalIF":2.5,"publicationDate":"2016-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34306478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2008-2011.","authors":"Aditi Dey,&nbsp;Stephanie Knox,&nbsp;Han Wang,&nbsp;Frank H Beard,&nbsp;Peter B McIntyre","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This summary report on vaccine preventable diseases in Australia brings together the 3 most important national sources of routinely collected data on vaccine preventable diseases (notifications, hospitalisations and deaths) for all age groups for the period January 2008 to December 2011. The general trend towards improved control of disease is evident, particularly in the childhood years. Detailed results are available in 16 individual chapters. Although these data have limitations, which are discussed in detail in the body of the report, some clear trends are evident. Compared with the previous review period (2005-2007), there are continuing declines in the overall disease burden, driven by improving control of mumps, rubella, hepatitis B and meningococcal disease. There is an ongoing absence of disease due to polio and a continuing low incidence of tetanus. There have been continuing declines in the incidence of hepatitis A and B. However, there were 4 notified cases of diphtheria in 2011; prior to these reports there had been no notified diphtheria cases since 2001. Influenza and pertussis notifications have increased, whereas notifications and hospitalisations for mumps have remained stable and for meningococcal disease have declined. Influenza, pertussis and pneumococcal disease continue to contribute the greatest burden of serious disease.</p>","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 Suppl ","pages":"S1-70"},"PeriodicalIF":2.5,"publicationDate":"2016-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34409521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Australia's notifiable disease status, 2014: Annual report of the National Notifiable Diseases Surveillance System.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In 2014, 69 diseases and conditions were nationally notifiable in Australia. States and territories reported a total of 275,581 notifications of communicable diseases to the National Notifiable Diseases Surveillance System, an increase of 22% on the number of notifications in 2013. In 2014, the most frequently notified diseases were sexually transmissible infections (105,719 notifications, 38% of total notifications), vaccine preventable diseases (101,400 notifications, 37% of total notifications), and gastrointestinal diseases (40,367 notifications, 15% of total notifications). There were 17,411 notifications of bloodborne diseases; 8,125 notifications of vectorborne diseases; 1,942 notifications of other bacterial infections; 615 notifications of zoonoses and 2 notifications of quarantinable diseases.</p>","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 1","pages":"E48-145"},"PeriodicalIF":2.5,"publicationDate":"2016-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34403685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Infectious and congenital syphilis notifications associated with an ongoing outbreak in northern Australia.","authors":"Amy Bright,&nbsp;Johanna Dups","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"40 1","pages":"E7-10"},"PeriodicalIF":2.5,"publicationDate":"2016-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34403686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}